Latest Global Markets News

Page 2 of 67
Zimi has secured an exclusive three-year distribution agreement with Directed for retail, direct-to-consumer and direct-to-business sales across Australia and New Zealand. The deal gives its next-generation Matter devices access to more than 10,000 retail outlets, although commercial terms and guaranteed sales volumes remain undisclosed.
Sophie Babbage
Sophie Babbage
24 Sept 2026
Antipodes Global SMID Fund delivered a sharp improvement in FY2026, with profit attributable to unitholders rising to $22.73 million and net assets expanding more than eightfold to $183.65 million. The fund also added a new unit class and brought its P Class units to the ASX under ticker MIDS.
Claire Turing
Claire Turing
22 Sept 2026
JPMorgan Global Research Enhanced Index Equity Trust (ASX:JRH) reported a sharp rise in FY2026 operating profit, driven primarily by investment revaluation gains as net assets expanded to almost A$2 billion. Distributions also surged, although the result remains exposed to global equity markets, foreign exchange and derivatives.
Claire Turing
Claire Turing
14 Sept 2026
Kapstream Investment Trust will begin a 12-month on-market buy-back of its fully paid ordinary units, but has not disclosed a target quantity or dollar commitment. The responsible entity can pause or end the programme without notice.
Claire Turing
Claire Turing
10 Sept 2026
xReality Group (ASX: XRG) delivered a standout FY26 with total income up 43% to $20 million and EBITDA surging to $3.8 million, backed by rapid expansion of its Operator XR defence training platform.
Sophie Babbage
Sophie Babbage
31 Aug 2026
Magellan Infrastructure Fund (Currency Hedged) reported a $73.9 million profit for FY2026, down from $108.1 million the prior year, while boosting distributions to unitholders by over 270%.
Claire Turing
Claire Turing
28 Aug 2026
4DMedical’s CT:VQ™ lung imaging technology secured FDA clearance and CMS reimbursement, driving rapid adoption in top US medical centres and expanding its addressable market to $3 billion with new clinical programs and European contracts.
Ada Torres
Ada Torres
28 Aug 2026
SomnoMed reported a 3% revenue rise to $114.5 million and a 19% EBITDA increase to $10.9 million in FY26, navigating European market headwinds and a CEO transition while launching its Virtus device targeting sleep apnea with bruxism.
Ada Torres
Ada Torres
28 Aug 2026
Imricor Medical Systems and Philips have launched a combined interventional MR lab solution integrating Philips’ 1.5T BlueSeal MRI with Imricor’s MR-compatible systems, targeting cardiac electrophysiology and setting a new standard for MR-guided interventions.
Ada Torres
Ada Torres
28 Aug 2026
LTR Pharma is shifting gears from clinical trials to commercial rollout, securing US partnerships for ROXUS and reporting encouraging SPONTAN Phase II data that supports FDA approval ambitions.
Ada Torres
Ada Torres
28 Aug 2026
Delegat Group (NZX:DGL) reported a 20% jump in operating NPAT to NZD 61.5 million for FY26, driven by record EBITDA and a 4% rise in global case sales. The Board declared a 22-cent dividend, up 10%, while net debt fell by NZD 51.8 million.
Victor Sage
Victor Sage
28 Aug 2026
Austco Healthcare has delivered record FY26 financial results, driven by strong organic growth, acquisitions, and a growing software maintenance base, positioning the company for sustained earnings momentum.
Ada Torres
Ada Torres
27 Aug 2026

Browse the archive

Full archive